Single Intravenous Dose of Oritavancin for Treatment of Acute Skin and Skin Structure Infections Caused by Gram-Positive Bacteria: Summary of Safety Analysis from the Phase 3 SOLO Studies

G. Ralph Corey, Paul Manos, Greg Moeck et al.|Antimicrobial Agents and Chemotherapy|2018

Cited by 26